Search Results - "Barbaro, Andrea De Lerma"

Refine Results
  1. 1

    Irradiated CIITA-positive mammary adenocarcinoma cells act as a potent anti-tumor-preventive vaccine by inducing tumor-specific CD4+ T cell priming and CD8+ T cell effector functions by Mortara, Lorenzo, Frangione, Valeria, Castellani, Patrizia, De Lerma Barbaro, Andrea, Accolla, Roberto S.

    Published in International immunology (01-06-2009)
    “…In the present study, we investigated the possibility to use irradiated, non-replicating class II transcriptional activator (CIITA)-transfected tumor TS/A…”
    Get full text
    Journal Article
  2. 2

    Methylation of CIITA promoter IV causes loss of HLA-II inducibility by IFN-γ in promyelocytic cells by De Lerma Barbaro, Andrea, De Ambrosis, Alessandro, Banelli, Barbara, Pira, Giuseppina Li, Aresu, Ottavia, Romani, Massimo, Ferrini, Silvano, Accolla, Roberto S.

    Published in International immunology (01-11-2008)
    “…The human promyelocytic cell line THP-1 expresses high level of HLA class II (HLA-II) molecules after IFN-γ treatment. Here, we report a variant of THP-1 that…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Therapy-induced antitumor vaccination by targeting tumor necrosis factor-α to tumor vessels in combination with melphalan by Mortara, Lorenzo, Balza, Enrica, Sassi, Francesca, Castellani, Patrizia, Carnemolla, Barbara, De Lerma Barbaro, Andrea, Fossati, Sara, Tosi, Giovanna, Accolla, Roberto S, Borsi, Laura

    Published in European journal of immunology (01-12-2007)
    “…Treatment of tumor-bearing mice with mouse (m)TNF-α, targeted to tumor vasculature by the anti-ED-B fibronectin domain antibody L19(scFv) and combined with…”
    Get full text
    Journal Article
  5. 5

    Inflammation, inflammatory cells and angiogenesis: decisions and indecisions by Noonan, Douglas M., De Lerma Barbaro, Andrea, Vannini, Nicola, Mortara, Lorenzo, Albini, Adriana

    Published in Cancer and metastasis reviews (01-03-2008)
    “…Endothelial-immune cell cross-talk goes well beyond leukocyte and lymphocyte trafficking, since immune cells are able to intimately regulate vessel formation…”
    Get full text
    Journal Article
  6. 6

    Inhibition of Human T Cell Leukemia Virus Type 2 Replication by the Suppressive Action of Class II Transactivator and Nuclear Factor Y by Tosi, Giovanna, Pilotti, Elisabetta, Mortara, Lorenzo, De Lerma Barbaro, Andrea, Casoli, Claudio, Accolla, Roberto S.

    “…The master regulator of MHC-II gene transcription, class II transactivator (CIITA), acts as a potent inhibitor of human T cell leukemia virus type 2 (HTLV-2)…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Neutrophil and Natural Killer Cell Interactions in Cancers: Dangerous Liaisons Instructing Immunosuppression and Angiogenesis by Palano, Maria Teresa, Gallazzi, Matteo, Cucchiara, Martina, De Lerma Barbaro, Andrea, Gallo, Daniela, Bassani, Barbara, Bruno, Antonino, Mortara, Lorenzo

    Published in Vaccines (Basel) (16-12-2021)
    “…The tumor immune microenvironment (TIME) has largely been reported to cooperate on tumor onset and progression, as a consequence of the phenotype/functional…”
    Get full text
    Journal Article
  9. 9

    CIITA‐driven MHC‐II positive tumor cells: Preventive vaccines and superior generators of antitumor CD4+ T lymphocytes for immunotherapy by Frangione, Valeria, Mortara, Lorenzo, Castellani, Patrizia, De Lerma Barbaro, Andrea, Accolla, Roberto S.

    Published in International journal of cancer (01-10-2010)
    “…In our study, we have investigated whether tumors of distinct histological origin can be rejected if expressing CIITA‐driven MHC class II molecules. Moreover,…”
    Get full text
    Journal Article
  10. 10

    Metabolic Rewiring in the Tumor Microenvironment to Support Immunotherapy: A Focus on Neutrophils, Polymorphonuclear Myeloid-Derived Suppressor Cells and Natural Killer Cells by De Lerma Barbaro, Andrea, Palano, Maria Teresa, Cucchiara, Martina, Gallazzi, Matteo, Mortara, Lorenzo, Bruno, Antonino

    Published in Vaccines (Basel) (14-10-2021)
    “…Leukocytes often undergo rapid changes in cell phenotype, for example, from a resting to an activated state, which places significant metabolic demands on the…”
    Get full text
    Journal Article
  11. 11

    In Vivo Effects of A Pro-PO System Inhibitor on the Phagocytosis of Xenorhabdus Nematophila in Galleria Mellonella Larvae by De Lerma Barbaro, Andrea, Gariboldi, Marzia B, Mastore, Maristella, Brivio, Maurizio F, Giovannardi, Stefano

    Published in Insects (Basel, Switzerland) (22-08-2019)
    “…is a Gram-negative bacterium symbiont of the entomopathogen nematode whose immunosuppressive properties over host's immune response have been thoroughly…”
    Get full text
    Journal Article
  12. 12

    The complex liaison between cachexia and tumor burden (Review) by DE LERMA BARBARO, ANDREA

    Published in Oncology reports (01-10-2015)
    “…Cachexia is a wasting syndrome that afflicts end-stage cancer patients. Whereas a consensus statement for a definition of cachexia recently has been…”
    Get full text
    Journal Article
  13. 13

    Block of Stat‐1 activation in macrophages phagocytosing bacteria causes reduced transcription of CIITA and consequent impaired antigen presentation by Barbaro, AndreaDeLerma, Tosi, Giovanna, Frumento, Guido, Bruschi, Emanuele, D'Agostino, Antonella, Valle, Maria‐Teresa, Manca, Fabrizio, Accolla, Roberto S.

    Published in European journal of immunology (01-05-2002)
    “…The IFN‐γ‐induced HLA class II expression in human macrophages was drastically reduced after phagocytosis of Escherichia coli. HLA class II down‐modulation…”
    Get full text
    Journal Article
  14. 14

    New strategies of mammary cancer vaccination by Accolla, Roberto S, Frangione, Valeria, De Lerma Barbaro, Andrea, Mortara, Lorenzo

    Published in The breast journal (01-09-2010)
    “…A new strategy of vaccination against mammary tumors, extendible to tumors of distinct histological origin, based on the administration of tumor cells…”
    Get more information
    Journal Article
  15. 15

    Experimental therapeutic approaches to adenocarcinoma: The potential of tumor cells engineered to express MHC class II molecules combined with naked DNA interleukin-12 gene transfer by Mortara, Lorenzo, Giuliani, Luca, De Lerma Barbaro, Andrea, Accolla, Roberto S, Noonan, Douglas M

    Published in Surgical oncology (01-12-2007)
    “…Summary We have previously shown that TS/A murine mammary adenocarcinoma cells, induced to express high surface expression of MHC class II molecules by stable…”
    Get full text
    Journal Article
  16. 16

    The HLA class II transcriptional activator blocks the function of HIV‐1 Tat and inhibits viral replication by Accolla, Roberto S., Mazza, Stefania, Barbaro, AndreaDeLerma, Maria, Andrea De, Tosi, Giovanna

    Published in European journal of immunology (01-10-2002)
    “…The expression of HLA class II genes is under the control of a transcriptional activator, CIITA, encoded by the AIR‐1 locus. Here we show that CIITA inhibits…”
    Get full text
    Journal Article
  17. 17

    The MHC class II transactivator (CIITA) mRNA stability is critical for the HLA class II gene expression in myelomonocytic cells by De Lerma Barbaro, Andrea, Procopio, Francesco A., Mortara, Lorenzo, Tosi, Giovanna, Accolla, Roberto S.

    Published in European Journal of Immunology (01-02-2005)
    “…The human promyelocytic U937 cells express detectable levels of MHC class II (MHC‐II) molecules. Treatment with 12‐o‐‐tetradecanoyl phorbol 13‐acetate (TPA),…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Active suppression of the class II transactivator-encoding AIR-1 locus is responsible for the lack of major histocompatibility complex class II gene expression observed during differentiation from B cells to plasma cells by Sartoris, S, Tosi, G, De Lerma Barbaro, A, Cestari, T, Accolla, R S

    Published in European journal of immunology (01-10-1996)
    “…In this study the genetic control of major histocompatibility complex (MHC) class II gene expression during the transition from B cell to plasma cell has been…”
    Get more information
    Journal Article
  20. 20

    Inhibition of human TI cell leukemia virus type 2 replication by the suppressive action of class II transactivator and nuclear factor Y by Tosi, Giovanna, Pilotti, Elisabetta, Mortara, Lorenzo, De Lerma Barbaro, Andrea

    “…The master regulator of MHC-11 gene transcription, class II trans-activator (CIITA), acts as a potent inhibitor of human T cell leukemia virus type 2 (HTLV-2)…”
    Get full text
    Journal Article